Global Recombinant Albumin Market Research Report 2024

Publication ID:

PB505251758

Publication Date:

May 10, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Recombinant albumin is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.
The global Recombinant Albumin market was valued at US$ 75 million in 2023 and is anticipated to reach US$ 121.4 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.
The Recombinant Albumin market is primarily driven by the increasing demand for high-quality and safe albumin products in various medical and research applications. Recombinant albumin, produced using biotechnology methods, offers a reliable alternative to traditional plasma-derived albumin, with reduced risk of contamination and consistent quality. The growing prevalence of chronic diseases and the need for albumin in critical care settings, drug formulation, and cell culture contribute to market growth. Moreover, the emphasis on animal-free and sustainable sourcing aligns with the adoption of recombinant albumin. However, challenges include addressing the cost-effectiveness of recombinant production methods and ensuring scalability for large-scale production. Navigating regulatory approvals and market competition, while addressing pricing pressures, are ongoing concerns. The market's success relies on continuous innovation in recombinant protein technology, collaborations between biotechnology companies and pharmaceutical manufacturers, and comprehensive research to demonstrate the safety, efficacy, and cost benefits of recombinant albumin while addressing the evolving challenges associated with protein production, quality assurance, and market acceptance.
This report aims to provide a comprehensive presentation of the global market for Recombinant Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Albumin.
Report Scope
The Recombinant Albumin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
Segment by Type
OsrHSA
ScrHSA
Segment by Application
Cell Culture Media
Medical Supplements
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Recombinant Albumin Market Overview
1.1 Product Overview and Scope of Recombinant Albumin
1.2 Recombinant Albumin Segment by Type
1.2.1 Global Recombinant Albumin Market Value Comparison by Type (2024-2030)
1.2.2 OsrHSA
1.2.3 ScrHSA
1.3 Recombinant Albumin Segment by Application
1.3.1 Global Recombinant Albumin Market Value by Application: (2024-2030)
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.3.4 Other
1.4 Global Recombinant Albumin Market Size Estimates and Forecasts
1.4.1 Global Recombinant Albumin Revenue 2019-2030
1.4.2 Global Recombinant Albumin Sales 2019-2030
1.4.3 Global Recombinant Albumin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Albumin Market Competition by Manufacturers
2.1 Global Recombinant Albumin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Albumin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Albumin Average Price by Manufacturers (2019-2024)
2.4 Global Recombinant Albumin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Albumin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Albumin, Product Type & Application
2.7 Recombinant Albumin Market Competitive Situation and Trends
2.7.1 Recombinant Albumin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Recombinant Albumin Players Market Share by Revenue
2.7.3 Global Recombinant Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Albumin Retrospective Market Scenario by Region
3.1 Global Recombinant Albumin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Albumin Global Recombinant Albumin Sales by Region: 2019-2030
3.2.1 Global Recombinant Albumin Sales by Region: 2019-2024
3.2.2 Global Recombinant Albumin Sales by Region: 2025-2030
3.3 Global Recombinant Albumin Global Recombinant Albumin Revenue by Region: 2019-2030
3.3.1 Global Recombinant Albumin Revenue by Region: 2019-2024
3.3.2 Global Recombinant Albumin Revenue by Region: 2025-2030
3.4 North America Recombinant Albumin Market Facts & Figures by Country
3.4.1 North America Recombinant Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Albumin Sales by Country (2019-2030)
3.4.3 North America Recombinant Albumin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Albumin Market Facts & Figures by Country
3.5.1 Europe Recombinant Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Albumin Sales by Country (2019-2030)
3.5.3 Europe Recombinant Albumin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Albumin Market Facts & Figures by Country
3.6.1 Asia Pacific Recombinant Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Albumin Sales by Country (2019-2030)
3.6.3 Asia Pacific Recombinant Albumin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Recombinant Albumin Market Facts & Figures by Country
3.7.1 Latin America Recombinant Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Albumin Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Albumin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Albumin Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Albumin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Albumin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Albumin Sales by Type (2019-2030)
4.1.1 Global Recombinant Albumin Sales by Type (2019-2024)
4.1.2 Global Recombinant Albumin Sales by Type (2025-2030)
4.1.3 Global Recombinant Albumin Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Albumin Revenue by Type (2019-2030)
4.2.1 Global Recombinant Albumin Revenue by Type (2019-2024)
4.2.2 Global Recombinant Albumin Revenue by Type (2025-2030)
4.2.3 Global Recombinant Albumin Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Albumin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Albumin Sales by Application (2019-2030)
5.1.1 Global Recombinant Albumin Sales by Application (2019-2024)
5.1.2 Global Recombinant Albumin Sales by Application (2025-2030)
5.1.3 Global Recombinant Albumin Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Albumin Revenue by Application (2019-2030)
5.2.1 Global Recombinant Albumin Revenue by Application (2019-2024)
5.2.2 Global Recombinant Albumin Revenue by Application (2025-2030)
5.2.3 Global Recombinant Albumin Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Albumin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Albumedix
6.1.1 Albumedix Corporation Information
6.1.2 Albumedix Description and Business Overview
6.1.3 Albumedix Recombinant Albumin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Albumedix Recombinant Albumin Product Portfolio
6.1.5 Albumedix Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Recombinant Albumin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Recombinant Albumin Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Ventria (InVitria)
6.3.1 Ventria (InVitria) Corporation Information
6.3.2 Ventria (InVitria) Description and Business Overview
6.3.3 Ventria (InVitria) Recombinant Albumin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ventria (InVitria) Recombinant Albumin Product Portfolio
6.3.5 Ventria (InVitria) Recent Developments/Updates
6.4 NCPC
6.4.1 NCPC Corporation Information
6.4.2 NCPC Description and Business Overview
6.4.3 NCPC Recombinant Albumin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NCPC Recombinant Albumin Product Portfolio
6.4.5 NCPC Recent Developments/Updates
6.5 Oryzogen
6.5.1 Oryzogen Corporation Information
6.5.2 Oryzogen Description and Business Overview
6.5.3 Oryzogen Recombinant Albumin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Oryzogen Recombinant Albumin Product Portfolio
6.5.5 Oryzogen Recent Developments/Updates
6.6 HiMedia
6.6.1 HiMedia Corporation Information
6.6.2 HiMedia Description and Business Overview
6.6.3 HiMedia Recombinant Albumin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 HiMedia Recombinant Albumin Product Portfolio
6.6.5 HiMedia Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Albumin Industry Chain Analysis
7.2 Recombinant Albumin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Albumin Production Mode & Process
7.4 Recombinant Albumin Sales and Marketing
7.4.1 Recombinant Albumin Sales Channels
7.4.2 Recombinant Albumin Distributors
7.5 Recombinant Albumin Customers
8 Recombinant Albumin Market Dynamics
8.1 Recombinant Albumin Industry Trends
8.2 Recombinant Albumin Market Drivers
8.3 Recombinant Albumin Market Challenges
8.4 Recombinant Albumin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂